Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Health Topics: Page 2
Quest Diagnostics seeks to get a jump on PFAS testing in communities
By
Liz Carey
Researchers often use people’s blood PFAS levels as a proxy for exposure to perfluoroalkyl and polyfluoroalkyl substances, the "forever chemicals" found in certain products and the environment.
February 13, 2024
CRISPR-repaired T cells cure lethal hyperinflammation in mice
By
Nick Paul Taylor
Memory T cells repaired using CRISPR-Cas9 can cure lethal hyperinflammation in mice, suggesting the approach may improve outcomes in a disease with a five-year probability of survival of around 50%.
February 2, 2024
Blood test for Alzheimer’s shows high accuracy in study
By
Matt Limb
Scientists have hailed study results showing the high accuracy of a blood test that “could revolutionize” diagnosis of Alzheimer’s disease.
January 31, 2024
Researchers ID potential predictive biomarkers for CVD in type 2 diabetes
By
LabPulse.com staff writers
An analysis conducted by an international research team has identified 13 biomarkers that may improve the accuracy of predicting risk of cardiovascular disease (CVD) in people with type 2 diabetes.
January 25, 2024
Invitae sells reproductive health assets to Natera
By
LabPulse.com staff writers
Invitae on Monday has completed the sale of some of its reproductive health assets, including carrier screening and noninvasive prenatal screening, to Natera.
January 22, 2024
Researchers develop sensitive blood test for gene expression in the brain
By
Nick Paul Taylor
Analysis of molecules that travel from the brain into blood could enable noninvasive monitoring of gene expression in the organ, according to research published in Nature Biotechnology.
January 19, 2024
Optithera, ELNA Medical Group, Génome Québec partner on diabetes complications risk assessment test
By
LabPulse.com staff writers
Optithera, ELNA Medical Group, and Génome Québec have signed an agreement to further develop and distribute a genomic test to predict the risk of complications in patients with type 2 diabetes.
January 18, 2024
First FDA-approved CRISPR-based gene therapy cleared for 2nd indication
By
LabPulse.com staff writers
A month after the U.S. Food and Drug Administration (FDA) approved Vertex Pharmaceuticals’ and CRISPR Therapeutics’ Casgevy for the treatment of sickle cell disease, the agency has given it a second U.S. regulatory approval ahead of schedule.
January 17, 2024
Study: Focused ultrasound improves Alzheimer’s drug delivery
By
Matt Limb
Alzheimer’s disease researchers have reported promising results from using aducanumab infusions combined with focused ultrasound to reduce levels of cerebral amyloid-beta (Aβ) plaques.
January 17, 2024
Myrobalan Therapeutics completes $24M series A financing round
By
LabPulse.com staff writers
Biotech company Myrobalan Therapeutics completed a $24 million series A financing round Wednesday.
January 11, 2024
Gene therapy, companion diagnostic hit milestones for hemophilia A
By
Liz Carey
Six months after the FDA approved a one-time gene therapy for severe hemophilia A reportedly priced around $2.5 million per patient, the Center for Inherited Blood Disorders, a 340B treatment center in California, has announced the drug's first infusion.
January 11, 2024
Health Canada approves Pfizer’s hemophilia gene therapy
By
LabPulse.com staff writers
Health Canada, Canada’s regulatory agency, has approved Pfizer's Beqvez (fidanacogene elaparvovec) as a gene therapy treatment for adults with moderately severe to severe hemophilia B.
January 3, 2024
Previous Page
Page 2 of 69
Next Page